Programme at a glance

Programme at a glance, Paris

Thursday, 4 April 2019
00.01 - 23.59
WCO-IOF-ESCEO
14.30 - 17.00
Actualités et controverses sur l’arthrose et l’ostéoporose
‣ Symposium conjointement organisé par la Société Française de Rhumatologie (SFR), le Groupe de Recherche et d’Informations sur les Ostéoporoses (GRIO), l’International Osteoporosis Foundation (IOF) et l’European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).
Chairpersons: ‣ Leith Zakraoui, ‣ Bernard Cortet, ‣ Thierry Thomas
‣ 14h30 : Produits laitiers fermentés et santé osseuse Emmanuel Biver
‣ 14h55 : L’arthrose, une histoire d’alimentation ? Jérémie Sellam
‣ 15h20 : L’arthrose, une maladie inflammatoire ? Florent Eymard
‣ 15h45 : Vitamine D, arthrose et ostéoporose Etienne Cavalier
‣ 16h10 : L’arthrose rachidienne existe-t-elle ? François Rannou
‣ 16h35 : La place de la vertébroplastie, les données sont-elles solides ? Bernard Cortet
‣ 17h00 : Conclusion Thierry Thomas

Symposium organisé en langue française.

17.15 - 20.00
WCO-IOF-ESCEO - OPENING CEREMONY
Chairpersons: ‣ John A. Kanis, ‣ Jean‑Yves Reginster
17.15
Best clinical papers published in 2018
‣ René Rizzoli
18.00
Beyond nutrients: health effects of the dairy matrix
‣ Arne Astrup
18.30
2018 update of the European guidelines for the diagnosis and management of osteoporosis (ESCEO-IOF)
‣ René Rizzoli
19.00
Plenary Lecture: Disease in Art Painting
‣ Davide Lazzeri
19.30
Opening of the meeting
‣ Cyrus Cooper (IOF President, ESCEO Vice‑President)
19.40
Presentation of the 2019 ESCEO Medal of Excellence
19.45
Presentation of the ESCEO-IOF Herbert Fleisch Medal
19.50
Presentation of the IOF Medal of Achievement
19.55
Presentation of the IOF Olof Johnell Science Award
Friday, 5 April 2019
00.01 - 23.59
WCO-IOF-ESCEO
08.00 - 09.00
SYMPOSIA
Patients' preferences for anti-osteoarthritis treatment: A cross-European Discrete Choice Experiment: outcomes of an experts consensus meeting organized under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).
Chairpersons: ‣ Mickaël Hiligsmann, ‣ Elaine M. Dennison
‣ 08:00: Welcome and introduction Mickaël Hiligsmann
‣ 08:05: Identification prioritization of important attributes of OA treatment Elaine M. Dennison
‣ 08:20: Results from the cross-European discrete choice experiment Mickaël Hiligsmann
‣ 08:35: Discussion Elaine M. Dennison
‣ 08:55: Conclusion Mickaël Hiligsmann
Osteosarcopenic obesity: enough evidence for a distinct entity: outcomes of an ESCEO experts consensus meeting organized under the auspices of the World Health Organization Collaborating Center for Public Health Aspects of Musculo-skeletal Health and Ageing
Chairpersons: ‣ Islene Araujo de Carvalho, ‣ Roger Fielding
‣ 08:00: Introduction Stefania Maggi
‣ 08:05: Osteosarcopenic obesity: Facts and evidence supporting a distinct entity Jürgen Bauer
‣ 08:20: Osteosarcopenic obesity: Lack of evidence supporting a distinct entity Alfonso Cruz Jentoft
‣ 08:35: Discussion Jürgen Bauer
‣ 08:55: Conclusion Roger Fielding
Panel: ‣ Islene Araujo de Carvalho, ‣ Jürgen Bauer, ‣ Olivier Bruyère, ‣ Roland D. Chapurlat, ‣ Cyrus Cooper, ‣ Alfonso Cruz Jentoft, ‣ Elaine M. Dennison, ‣ Roger Fielding, ‣ John A. Kanis, ‣ Jean‑Marc Kaufman, ‣ Francesco Landi, ‣ Andrea Laslop, ‣ Médéa Locquet, ‣ Stefania Maggi, ‣ Eugene McCloskey, ‣ Simone Perna, ‣ Jean‑Yves Reginster, ‣ René Rizzoli, ‣ Yves Rolland, ‣ Pawel Szulc, ‣ Mila Vlaskovska
08.00 - 09.00
NON-SPONSORED SYMPOSIA
Real World Evidence in Metabolic Bone Disease
Chairperson: ‣ Daniel Prieto‑Alhambra
‣ Real world data for assessing the use, risks, and benefits of anti-osteoporosis therapies in actual practice conditions Daniel Prieto‑Alhambra
‣ Routinely collected data for the study of the epidemiology of fractures, and for characterising imminent fracture risk Bo Abrahamsen
‣ Health economics using real world data: an introduction Rafael Pinedo‑Villanueva
‣ Real world data for the study of orthopaedics and hip fracture care Alma Pedersen
What’s new in tendinopathies?
Chairperson: ‣ Jean‑François Kaux
‣ Introduction Olivier Bruyère
‣ Tendon physiopathology and imagery... What’s new ? Stijn Bogaerts
‣ Rehabilitation: eccentric or not eccentric? Which physiotherapy? Jean‑Louis Croisier
‣ Which efficacy for the new treatments ? Jean‑François Kaux
Emerging Biomarkers in Vitamin D Metabolism
Chairperson: ‣ Nasser Al‑Daghri
‣ Biomarker Discovery Nasser Al‑Daghri
‣ Vitamin D Biomarker Discovery Majed Alokail
‣ Validation Yousef  Al‑Saleh
Sarcopenia in older people: actual perspectives
Chairpersons: ‣ Nicola Veronese, ‣ Charlotte Beaudart
‣ The radiological evaluation of muscle mass in older people Giuseppe Guglielmi
‣ Physical performance in older people: actual evidence Olivier Bruyère
‣ The diagnosis of sarcopenia in older people: between research and clinical practice Nicola Veronese
Female Bone Project: a gynecological approach through routine assistance
Chairperson: ‣ Adriana Orcesi Pedro
‣ Opening: UNICAMP message for Bone Health Adriana Orcesi Pedro
‣ Bone mass and fracture risk during pregnancy and lactation Anna Valéria Gueldini de Moraes, Fernanda Garanhani de Castro Surita
‣ Update on management of osteoporosis in young women - special clinical situations Adriana Orcesi Pedro
‣ Evaluation and management of osteopenia and osteoporosis in breast cancer survivors César Cabello, Adriana Orcesi Pedro
‣ Question & Answers with audience
08.00 - 09.00
AVAILABLE SPONSORED BREAKFAST SYMPOSIUM
09.00 - 10.30
SCIENTIFIC SESSION I
Chairpersons: ‣ Jean‑Yves Reginster, ‣ John A. Kanis
09.00
Plenary Lecture 1
‣ When and why use a bone forming agent?
‣ Eugene McCloskey
09.30
Oral communication selected from abstracts
10.20
Presentation of the ESCEO-AgNovos Healthcare Young Investigator Awards
10.30 - 12.10
SCIENTIFIC SESSION II
Chairpersons: ‣ René Rizzoli, ‣ Cyrus Cooper
10.30
Plenary Lecture 2
‣ Bone fragility and its treatment in chronic renal failure
‣ Peter R. Ebeling
11.00
Presentation of the IOF President's Award
11.10
Oral communication selected from abstracts
14.00 - 15.00
MEET-THE-EXPERT SESSIONS
How to assess frailty in daily practice ?
‣ Evelien Gielen
Disorders of phosphate homeostasis
‣ Maria Luisa Brandi
Pre- and postnatal influences on bone and muscle health in children
‣ Nicholas Harvey
Strengths of recommendations for GIOP management
‣ Jonathan Adachi
New algorithm for the management of bone fragility in diabetes
‣ Serge Ferrari
14.00 - 15.00
Poster Viewing Session I
14.00 - 15.10
Oral presentation of selected posters
Chairperson: ‣ Tara Brennan‑Speranza
14.00 - 15.00
SYMPOSIA
Reassessment of the safety of anti-osteoarthritis medications: outcomes of an experts consensus meeting organized under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).
Chairpersons: ‣ Olivier Bruyère, ‣ Elaine M. Dennison
‣ 14:00: Welcome and scope of the problem Cyrus Cooper
‣ 14:05: Methodology of the ESCEO Working Group Cyrus Cooper
‣ 14:15: Safety of analgesics, non-steroidal anti-inflammatory drugs and opioids Nicholas Fuggle
‣ 14:30: Safety of SYSADOAs, intraarticular Hyaluronic Acid and intraarticular corticosteroids Tim McAlindon
‣ 14:45: Discussion Nigel K. Arden
‣ 14:55: Wrap-up and conclusions Nigel K. Arden
Determinants, consequences and potential solutions to poor adherence to anti-osteoporosis treatment: outcomes of an ESCEO-IOF experts consensus meeting organized under the auspices of the WHO Collaborating Centre for Public Health Aspects of Musculoskeletal Health and Aging
Chairpersons: ‣ Adolfo Diez‑Perez, ‣ Stefania Maggi
‣ 14:00: Welcome and scope of the problem Maria Luisa Brandi
‣ 14:05: Determinants of non-adherence to anti-osteoporosis medications Bernard Vrijens
‣ 14:20: Recommendations to improve adherence to anti-osteoporosis medications Mickaël Hiligsmann
‣ 14:35: Recommendations for additional research needed to improve adherence to anti-osteoporosis medications Bo Abrahamsen
‣ 14:45: Discussion (Leader : Sansin Tuzun)
‣ 15:00: Closure of the meeting Adolfo Diez‑Perez
15.00 - 17.00
SCIENTIFIC SESSION III
Chairpersons: ‣ Charlotte Beaudart, ‣ Bess Dawson‑Hughes
15.00
Plenary Lecture 3
‣ Early treatment of osteoarthritis
‣ Nigel K. Arden
15.30
Oral communication selected from abstracts
16.30
Plenary Lecture 4
‣ Guidelines for the management of osteoarthritis
‣ Jean‑Yves Reginster
15.00 - 16.45
COMMITTEE OF NATIONAL SOCIETIES SPECIAL PLENARY SESSION
‣ Clinical, social, ethical and economic burden of osteoporosis and fragility fractures
16.35
Presentation of the IOF Committee of National Societies Medal
16.45 - 17.00
IOF Calcium Academy Awards ceremony
Saturday, 6 April 2019
00.01 - 23.59
WCO-IOF-ESCEO
08.00 - 09.00
NON-SPONSORED SYMPOSIA
Vitamin D: as viewed by the laboratory
Chairperson: ‣ Etienne Cavalier
‣ Vitamin D: Optimal levels Harjit  Pal Bhattoa
‣ Vitamin D metabolites: Now and Beyond Etienne Cavalier
FLS in the UK 2014-2018: implementation, standards, quality improvement and benefits
Chairperson: ‣ Bo Abrahamsen
‣ FLS Implementation: An innovative service support model for secondary fracture prevention in the UK Will Carr
‣ Securing funding for service implementation and improvement - demonstrating the benefits and effectiveness of fracture liaison services Tim Jones
‣ Vertebral Fracture Identification – meeting the challenge of FLS standards Jill Griffin
Non-pharmacological treatment of low back pain
Chairperson: ‣ Alexandr Barulin
‣ Cognitive-behavioral therapy in the treatment of chronic back pain Olga Kurushina
‣ Biomechanical aspects for understanding of non-specific low-back pain Alexandr Barulin
‣ Kinesiotaping in the correction of myofascial back pain Bogdan Kalinchenko
‣ New approaches to the correction of pain in patients with peripheral paralysis Olga Agarkova
Learning on Common Diseases by Understanding the Rare Disorders: The Case of Bone Fragility
Chairperson: ‣ Maria Luisa Brandi
‣ Taxonomy of Metabolic Bone Diseases Laura Masi
‣ FD-MAS Guidelines Neveen Hamdy
‣ Hypophosphatasia in the adults Christian Roux
‣ Phosphate wasting disorders in the adults Kassim Javaid
Are current treatment recommendations for Osteoarthritis adapted to old/very old patients ?
Chairpersons: ‣ Emmanuel Maheu, ‣ Odile Levy‑Raynaud
‣ How to manage NSAID in the Elderly in knee, hip or hand osteoarthritis treatment? Christian Cadet
‣ Are guidelines for the management of osteoarthritis adapted to very old patients: how to manage opioids in the Elderly in knee, hip or hand osteoarthritis? Agnès Portier
‣ Exercise and weight loss in the management of knee/hip OA in very old patients: current data and how to prescribe Jean‑Laurent Le Quintrec
‣ Total joint replacement of knee or hip in osteoarthritis management of very old patients, is it possible: current evidence and how to proceed? Emmanuel Maheu
08.00 - 09.00
SYMPOSIUM
Recommendations for the conduct of the economic evaluation in osteoporosis: outcomes of an experts consensus meeting organized under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Osteoporosis Foundation (IOF) USA branch
Chairpersons: ‣ Stuart Silverman, ‣ Mickaël Hiligsmann
‣ 08:00: Welcome and scope of the problem Stuart Silverman
‣ 08:05: Recommendations for the conduct of economic evaluations in osteoporosis: a summary from an ESCEO-IOF USA Working Group Mickaël Hiligsmann
‣ 08:25: Challenges, uncertainties and future research agenda for the conduct of economic evaluations in osteoporosis: a summary from an ESCEO-IOF USA Working Group Stuart Silverman
‣ 08:40: Discussion Panel
‣ 08:55: Conclusion Mickaël Hiligsmann
Panel: ‣ Susan Bukata, ‣ Deborah T.  Gold, ‣ Philippe Halbout, ‣ Mickaël Hiligsmann, ‣ Famida Jiwa, ‣ Mike Lewiecki, ‣ Daniel Pinto, ‣ Jean‑Yves Reginster, ‣ Kenneth Saag, ‣ Stuart Silverman, ‣ Anna N. A. Tosteson
08.00 - 09.00
AVAILABLE INDUSTRY-SPONSORED BREAKFAST SYMPOSIUM
08.00 - 09.00
EUGMS-IOF-ESCEO Symposium
‣ SARCOPENIA COMES OF AGE
Chairperson: ‣ Stefania Maggi
‣ What is new in the definition of sarcopenia? Alfonso Cruz Jentoft
‣ Diagnosing sarcopenia in clinical practice Yves Rolland
‣ Diet and exercise to treat sarcopenia Jürgen Bauer
09.00 - 10.30
SCIENTIFIC SESSION IV
Chairpersons: ‣ Thierry Thomas, ‣ Stefania Maggi
09.00
Plenary Lecture 5
‣ What spaceflight has taught us regarding bone and muscle
‣ Laurence Vico
09.30
Oral communication selected from abstracts
10.20
Presentation of the ESCEO-IOF Pierre Meunier Young Scientist Award
10.30 - 12.10
SCIENTIFIC SESSION V
Chairpersons: ‣ Bernard Cortet, ‣ Elaine M. Dennison
10.30
Plenary Lecture 6
‣ Pharmacological agents for the treatment of sarcopenia
‣ Roger Fielding
11.00
Oral communication selected from abstracts
14.00 - 15.00
MEET-THE-EXPERT SESSIONS
Local therapies in osteoarthritis management
‣ François Rannou
Vitamin D and osteoarthritis
‣ Tim McAlindon
Fracture Liaison Services: models and fracture risk reduction
‣ Kassim Javaid
Local Bone Treatment in Osteoporosis (supported by an Unrestricted Educational Grant from Agnovos Healthcare)
‣ Andreas Kurth
14.00 - 15.00
SYMPOSIUM
Diabetes and Osteoarthritis: outcomes of an ESCEO experts consensus meeting organized under the auspices of the World Health Organization Collaborating Center for Public Health Aspects of Musculo-skeletal Health and Ageing
Chairpersons: ‣ Elaine M. Dennison, ‣ Marc Hochberg
‣ 14:00: Introduction Roland D. Chapurlat
‣ 14:05: Impact of diabetes mellitus on osteoarthritis incidence and progression Nicola Veronese
‣ 14:20 Management of osteoarthritis in diabetic patients Daniel Uebelhart
‣ 14:35 Discussion André Scheen, Islene Araujo de Carvalho
‣ 14:55 Conclusion Elaine M. Dennison
Panel: ‣ Jaime Branco, ‣ Olivier Bruyère, ‣ Roland D. Chapurlat, ‣ Cyrus Cooper, ‣ Elaine M. Dennison, ‣ Gabriel Herrero‑Beaumont, ‣ Marc Hochberg, ‣ Andrea Laslop, ‣ Emmanuel Maheu, ‣ Jean‑Yves Reginster, ‣ René Rizzoli, ‣ Roland Roth, ‣ Lucio C. Rovati, ‣ André Scheen, ‣ Daniel Uebelhart, ‣ Nicola Veronese, ‣ Mila Vlaskovska
14.00 - 15.00
Poster Viewing Session II
14.00 - 15.10
Oral presentation of selected posters
Chairperson: ‣ Tara Brennan‑Speranza
14.00 - 15.00
Effects of biologics on bone in chronic arthritis
‣ Osvaldo D. Messina
15.00 - 17.00
SCIENTIFIC SESSION VI
Chairpersons: ‣ Radmila Matijevic, ‣ Fanny Buckinx
15.00
Plenary Lecture 7
‣ Tools for estimating fracture probability
‣ John A. Kanis
15.40
Oral communication selected from abstracts
16.30
Plenary Lecture 8
‣ Osteoporosis screening and fracture risk reduction
‣ Cyrus Cooper
17.00 - 18.30
AVAILABLE INDUSTRY-SPONSORED SYMPOSIUM
17.00 - 18.30
AVAILABLE INDUSTRY-SPONSORED SYMPOSIUM
Sunday, 7 April 2019
00.01 - 23.59
WCO-IOF-ESCEO
08.00 - 09.00
NON-SPONSORED SYMPOSIA
Bone structure in chronic arthritides
Chairpersons: ‣ Osvaldo D. Messina, ‣ Cristiano A. F. Zerbini
‣ Biologic agents and bone loss in rheumatoid arthritis Willem Lems
‣ Non invasive measurement of erosive disease with QCT and MRI in rheumatoid arthritis Jonathan D. Adachi
‣ Value and limitations in HRpQCT imaging in chronic arthritides. Current status and future directions Klaus Engelke
IOF-FFN Joint symposium - Moving from treatment to prevention of new fractures
Chairpersons: ‣ Kristina Åkesson, ‣ Matt Costa
‣ Getting the stars on the map Thierry Thomas
‣ What are the potential uncertainties for trauma surgeons - e.g. fracture healing Andy Gray
‣ The future of surgical fixation in fragile bone Matt Costa
‣ Monitoring patients and tools for getting better Kassim Javaid
‣ Capture the Fracture mentorship programme Donncha O’Gradaigh
Regenerative Medicine in degenerative joint diseases
Chairperson: ‣ George Skarpas
‣ Regenerative Medicine definitions, techniques and joint applications. Where do we stand now? George Skarpas
‣ Guidelines, Theories, Practice and Regulatory mechanisms for Stem Cell Therapy George Samoutis
‣ The role of regenerative medicine in degenerative conditions of the spine. Is there really a role for it? Elias Papadopoulos
‣ Regenerative medicine techniques need specially designed and individualized rehabilitation protocols for optimal results Eirini Kontopoulou
Women's special issues: osteoporosis 
Chairperson: ‣ Adriana Orcesi Pedro
‣ Risk factors for osteoporosis: Frax-based intervention and assessment thresholds in Brazil Ben‑Hur Albergaria
‣ Osteoporosis prevention and treatment on special situations during women's reproductive period Adriana Orcesi Pedro
‣ Update on efficacy and safety of post-menopause hormone therapy and fracture prevention Bruno Muzzi Camargos
‣ Question & Answers with audience
08.00 - 09.00
AVAILABLE INDUSTRY-SPONSORED BREAKFAST SYMPOSIUM
08.00 - 09.00
SYMPOSIA
New insights in the management of Osteoarthritis: an update of the ESCEO algorithm for the management of the Osteoarthritis
Chairpersons: ‣ François Rannou, ‣ Cyrus Cooper
‣ 08:00 Welcome Cyrus Cooper
‣ 08:05 The 2014-2016 ESCEO Algorithm for the management of the Osteoarthritis Olivier Bruyère
‣ 08:15 New insights in the management of Osteoarthritis Cyrus Cooper
‣ 08:30 The updated ESCEO algorithm for the management of knee Osteoarthritis : Assessment of the various treatment modalities by GRADE Nicola Veronese
‣ 8:55 Discussion Roland Roth
Selection of relevant outcomes in sarcopenia: a Discrete Choice Experiment. Outcomes of an ESCEO consensus meeting
Chairpersons: ‣ Charlotte Beaudart, ‣ Mickaël Hiligsmann
‣ 08:00: Welcome and introduction Mickaël Hiligsmann
‣ 08:05: Identification and prioritization of important outcomes for patients in sarcopenia Charlotte Beaudart
‣ 08:20: A cross-european discrete choice experiment to assess patients’ preferences for sarcopenia outcomes Mickaël Hiligsmann
‣ 08:40: Discussion Alfonso Cruz Jentoft, Islene Araujo de Carvalho
‣ 08:55: Conclusion Charlotte Beaudart
Panel: ‣ Jürgen Bauer, ‣ Charlotte Beaudart, ‣ Olivier Bruyère, ‣ Cyrus Cooper, ‣ Alfonso Cruz Jentoft, ‣ Mickaël Hiligsmann, ‣ Francesco Landi, ‣ Stefania Maggi, ‣ Jean‑Yves Reginster, ‣ René Rizzoli, ‣ Yves Rolland
08.00 - 09.00
ESPRM-IOF-ESCEO Joint Session
WIN - What is new in Physical and Rehabilitation Medicine on Osteoarthritis
Chairpersons: ‣ Fitnat Dincer, ‣ Michael Quittan
‣ W.I.N. - What is new in Hand Osteoarthritis? Update in Physical and Rehabilitation Medicine on Hand Osteoarthritis Fitnat Dincer
‣ W.I.N. - What is new in Knee Osteoarthritis? Update in Physical and Rehabilitation Medicine on Knee Osteoarthritis Michael Quittan
‣ W.I.N - What is New in Hip Osteoarthritis? Update in Physical and Rehabilitation Medicine on Hip Osteoarthritis Raquel Valero
09.00 - 10.00
MEET-THE-EXPERT SESSIONS
Obesity, bone and muscle
‣ Roland D. Chapurlat
Androgens: a role in bone and muscle disorders management?
‣ Jean‑Marc Kaufman
Atypical femoral fracture: stage in 2019
‣ Emmanuel Biver
Pitfalls in identification of vertebral fracture
‣ Christian Roux
Muscle strength/power assessment and outcomes
‣ Olivier Bruyère, ‣ Charlotte Beaudart, ‣ Mylène Aubertin‑Leheudre
10.00 - 12.00
SCIENTIFIC SESSION VII
Chairpersons: ‣ Şansın Tüzün, ‣ Famida Jiwa
10.00
Plenary Lecture 9
‣ Vitamin D: how much is too much?
‣ Bess Dawson‑Hughes
10.40
Oral communication selected from abstracts
11.30
Plenary Lecture 10
‣ Dietary protein, dairy and bone: devils or angels?
‣ René Rizzoli
12.00 - 13.00
NON-SPONSORED SYMPOSIA
Osteoarthritis and vascular aging
Chairperson: ‣ Sekib Sokolovic
‣ Introduction Sekib Sokolovic
‣ The impact of osteoarthritis on aging Sansin Tüzün
‣ The crosstalk between vessels, bone and cartilage: does it exist Marius Miglinas
‣ Osteaorthritis and vascular aging Sekib Sokolovic
Approach to Osteoporotic Hip Fractures
Chairpersons: ‣ Berrin Durmaz, ‣ Sema Oncel
‣ Osteoporotic Hip Fractures: Are we able to prevent? Yesim Kirazli
‣ Pharmacological Treatment after Hip Fractures: When and How? Ozlem El
‣ Adherence to Pharmacological Treatment of Osteoporosis Yesim Gokce Kutsal
‣ Rehabilitation after Hip Fractures Funda Calis
‣ Prevention of Complications Following Hip Fractures Ozlen Peker
Osteonecrosis of the jaw management in the clinical setting
Chairperson: ‣ Bruno Muzzi Camargos
‣ Pathophysiology and Risk Factors Oscar Rosero Olarte
‣ Biochemical markers and Imaging use on ONJ Bruno Muzzi Camargos
‣ Osteosteoporosis Therapies and ONJ. Adriana Medina Orjuella
‣ Clinical scenarios #1: Oral invasive procedures pre-op patients Monique Chalem
‣ Clinical scenarios #2: Oral invasive procedures pre-op patients Ana Karina Sarmiento Lievano
Osteosarcopenia: Elucidating bone, muscle and fat interactions
Chairperson: ‣ Gustavo Duque
‣ Osteosarcopenia: Where bone, muscle and fat collide Gustavo Duque
‣ Diagnostic approach to osteosarcopenia Bjoern Buering
‣ Osteosarcopenia: Potential Therapeutic Interventions Liang‑Kung Chen
Exercice with or without nutrition as countermeasures of dynapenia in older adults
Chairpersons: ‣ Bertrand Fougère, ‣ Fanny Buckinx, ‣ Mylène Aubertin‑Leheudre
‣ How to maintain muscle quality: the secret of a successful aging Bertrand Fougère
‣ Exercise to prevent muscle function in dynapenic or non-dynapenic older adults: one fits for all? Mylène Aubertin‑Leheudre
‣ Impact of nutrition during exercise intervention on muscle adaptation in older adults Fanny Buckinx